comparemela.com
Home
Live Updates
Composition of Matter Patent for QN-302 Granted by United : comparemela.com
Composition of Matter Patent for QN-302 Granted by United
CARLSBAD, Calif., March 21, 2023 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (“Qualigen” or “the Company,” Nasdaq: QLGN), a diversified life sciences...
Related Keywords
United States ,
Jules Abraham ,
Michael Poirier ,
Exchange Commission ,
European Patent Office ,
Partners Inc ,
Qualigen Therapeutics Inc ,
Aboutqualigentherapeutics Inc ,
Nasdaq ,
Trademarks Office ,
Orphan Drug Designation ,
United States Patent ,
Investigational New Drug ,
Gastrointestinal Stromal Tumors ,
Drug Designation ,
Qualigen Therapeutics ,
Fast Track ,
Orphan Drug ,
Private Securities Litigation Reform Act ,
Nasdaq Qlgn ,
Nc ,
Algn ,
N 302 ,
Ancreaticcancer ,
comparemela.com © 2020. All Rights Reserved.